BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24907040)

  • 1. Purification and characterization of paraoxonase 1 (PON1) from Swiss Black, Holstein, and Montofon bovines.
    Erzengin M; Demir D; Arslan M; Sinan S
    Appl Biochem Biotechnol; 2014 Aug; 173(7):1597-606. PubMed ID: 24907040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of Holstein bull semen paraoxonase 1 (PON1) by hydrophobic interaction chromatography and investigation of its inhibition kinetics by heavy metals.
    Dedeoğlu N; Arslan M; Erzengin M
    Biol Trace Elem Res; 2014 Apr; 158(1):29-35. PubMed ID: 24563030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde.
    Bilen Ç; Beyaztaş S; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):440-6. PubMed ID: 22233542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of bovine serum paraoxonase and its immobilization on Eupergit C 250 L by covalent attachment.
    Sayın M; Guler OO
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):69-74. PubMed ID: 24679050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
    Khersonsky O; Tawfik DS
    Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification, characterization, and investigation of in vitro inhibition by metals of paraoxonase from different sheep breeds.
    Erol K; Gençer N; Arslan M; Arslan O
    Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):125-30. PubMed ID: 22947096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals.
    Gençer N; Arslan O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):134-40. PubMed ID: 19084484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
    Bayrak A; Bayrak T; Demirpençe E; Kılınç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides.
    Ekinci D; Sentürk M; Beydemir S; Küfrevioğlu OI; Supuran CT
    Chem Biol Drug Des; 2010 Dec; 76(6):552-8. PubMed ID: 21040495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and kinetic properties of rabbit liver paraoxonase 1.
    Bayrak T; Bayrak A; Demirpençe E; Kilinç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1791-5. PubMed ID: 20627828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative purification method for human serum paraoxonase 1 and its interactions with anabolic compounds.
    Demir D; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016; 31(2):247-52. PubMed ID: 25792501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple procedures for purification and stabilization of human serum paraoxonase-1.
    Golmanesh L; Mehrani H; Tabei M
    J Biochem Biophys Methods; 2008 Apr; 70(6):1037-42. PubMed ID: 17928061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.
    Harel M; Aharoni A; Gaidukov L; Brumshtein B; Khersonsky O; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL; Tawfik DS
    Nat Struct Mol Biol; 2004 May; 11(5):412-9. PubMed ID: 15098021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.